BioSphere Medical, Inc. to Present at the 12th Annual Needham Growth Stock Conference

Published: Jan 07, 2010

ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD) – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – announced today that Martin Joyce, its executive vice president and chief financial officer, is scheduled to present at the 12th Annual Needham Growth Stock Conference on Thursday, January 14, 2010 at 8:40 a.m. eastern time. The conference will be held at the New York Palace Hotel in New York City.

Back to news